Lipid based nanocarriers with different lipid compositions for topical delivery of resveratrol: Comparative analysis of characteristics and performance

Journal of Drug Delivery Science and Technology

Volumn 24, Issue 6, 2014, Pages 591-600

  Sun, R ^a   Zhao, G ^a   Ni, S ^a   Xia, Q ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Crystallisation; Nanostructured lipid carrier; Resveratrol; Skin penetration; Solid lipid nanoparticle

Indexed keywords

LIPID; NANOCARRIER; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; FREEZE DRYING; HYDROPHOBICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIPID COMPOSITION; NONHUMAN; PARTICLE SIZE; SKIN PERMEABILITY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84921783231     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(14)50124-4     Document Type: Article

References (57)

1. Wu CF, Yang J.Y, Wang F., Wang X.X. - Resveratrol: botanical origin, pharmacological activity and applications. - Chin. J. Nat. Med, 11, 1-15, 2013.
2. Amn A, Chaumeil J, Star S., Charrueau C. - Administration of resveratrol what formulation solutions to bioavailability limitations? - J. Control Release, 158, 182-193, 2012.
3. Dolinsky VW, Chan A.Y., Robillard Frayne I., Light P E., Des Rosiers C., Dyck J. R. - Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1 - Circulation, 119, 1643-1652, 2009.
4. Jang M. - Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. - Science, 275, 218-220, 1997.
5. Brown VA, Patel K.R., Viskaduraki M., Crowell J.A., Perloff M., Booth T.D., et al. - Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis - Cancer Res., 70, 9003-9011, 2010.
6. Stelter P., Ulrich H.D. - Control of spontaneous and damage - induced mutagenesis by SUMO and ubiquitin conjugation - Nature, 425, 188-191, 2003.
7. Alberdi G., Rodriguez V.M, Miranda J., Macarulla M T, Chur-ruca I., Portillo M.P - Thermogenesis is involved in the body-fat lowering effects of resveratrol in rats. - Food Chem., 141, 1530-1535, 2013.
8. Hrenn A., Steinbrecher T, Labahn A., Schwager J., Schempp C M., Merfort I. - Plant phenolics inhibit neutrophil elastase. - Planta Med., 72, 1127-1131, 2006.
9. Docherty J.J., Fu MM, Hah J.M., Sweet T.J., Faith S.A., Booth T. - Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. - Antivir Res., 67, 155-162, 2005.
10. Scognamiglio I., De Stefano D., Campani V., Mayol L., Carnuccio R, Fabbrocini G., et al. - Nanocarriers for topical administration of resveratrol: a comparative study - Int. J. Pharm, 440, 179-187, 2013.
11. Pervaiz S, Holme A.L - Resveratrol: its biologic targets and functional activity. - Antioxid. Redox. Sign., 11, 2851-2897, 2009
12. Beekman K.B., Ames B.N. - The free radical theory of aging matures - Physiol Rev, 78, 547-581, 1998
13. Delmas D., Aires V., Limagne E., Dutartre P., Mazue F., Ghiringhelli F, et al. - Transport, stability, and biological activity of resveratrol. - Ann. NY. Acad. Sci., 1215, 48-59, 2011.
14. Gokce EH., Korkmaz E., Deliera E., Sandn G., Bonferoni M C, Ozer O - Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. - Int. J Nanomed., 7, 1841-1850, 2012
15. Ansari K.A, Vavia P R, Trotta F, Cavalli R. - Cyclodextrin-based nanosponges for delivery of resveratrol in vitrocharacterisation, stability, cytotoxicity and permeation study. - AAPS Pharmscitech, 12, 279-286, 2011.
16. Zillich O.V., Schweiggert-Weisz U., Hasenkopf K., Eisner P., Kerscher M - Release and in viro skin permeation of polyphenols from cosmetic emulsions. - Int. J Cosmet. Sci., 35, 491-501, 2013
17. Detoni C.B., Souto G.D., Maurer da Silva A.L, Pohlmann A.R., Guterres S.S - Photostabihty and skin penetration of different e-resveratrol-loaded supramolecular structures - Photochem. Photobiol., 88, 913-921, 2012.
18. Maali A., Mosavian M.T.H - Preparation and application of nanoemulsions in the last decade (2000-2010). - J. Disper Sci Tech., 34, 92-105, 2013.
19. Xavier F.H., Silva KGH. Farias LEG, Morais A.R.V., Alencar E.N, Araujo I.B., et al. - Prospective study for the development of emulsion systems containing natural oil products. - J Drug Deliv Sci. Tech., 22, 367-372, 2012.
20. Muller R., Shegokar R, Keck C. - 20 years of lipid nanoparticles (SLN NLC): present state of development industrial applications. - Curr. Drug Discov Tech, 8, 207-227, 2011
21. Mehnert W., Mader K. - Solid lipid nanoparticles - Production, characterization and applications - Adv. Drug Deliver. Rev., 47, 165-196, 2001.
22. Pardeike J., Hommoss A., Muller R.H. - Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products - Int J Pharm, 366, 170-184, 2009
23. Teeranachaideekul V, Souto E.B., Junyaprasert V.B., Muller R.H. - Cetyl palmitate-based NLC for topical delivery of coenzyme Q(10) - Development, physicochemical characterization and in vitro release studies. - Eur J. Pharm. Biopharm., 67, 141-148, 2007
24. Teeranachaideekul V., Boonme P., Souto E.B., Mueller R.H., Junyaprasert V B. - Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. - J. Control. Release, 128, 134-141, 2008.
25. Fan H., Liu G, Huang Y., Li Y, Xia Q - Development of a nanostructured lipid carrier formulation for increasing photo-stability and water solubility of phenylethyl resorcinol. - Appl Surf Sci., 288, 193-200, 2014.
26. Kasongo KW, Muller R.H., Walker R B - The use of hot and cold high pressure homogenization to enhance the loading capacity and encapsulation efficiency of nanostructured lipid carriers for the hydrophilic antiretroviral drug, didanosine for potential administration to paediatric patients. - Pharm Dev. Tech., 17, 353-362, 2012.
27. Zheng K., Zou A.H., Yang X M, Liu F., Xia Q., Ye R.Q., et al. - The effect of polymer-surfactant emulsifying agent on the formation and stability of alpha-hpoic acid loaded nanostructured lipid carriers (NLC) - Food Hydrocolloid., 32, 72-78, 2013.
28. Pardeike J., Weber S, Haber T., Wagner J., Zarfl H P, Plank H., et al. - Development of an Itraconazole - loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. - Int J Pharm., 419, 329-338, 2011
29. Lin X., Li X., Zheng L, Yu L., Zhang Q., Liu W. - Preparation and characterization of monocaprate nanostructured lipid carriers. - Colloids Surf. A, 311, 106-111, 2007.
30. Wang J-J, Liu K-S., Sung K., Tsai C-Y, Fang J-Y - Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. - Eur. J. Pharm. Sci., 38, 138-146, 2009.
31. Mendes A.I., Silva A.C., Catita J A.M., Cerqueira R, Gabriel C, Lopes C M. - Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa Improving antifungal activity. - Colloids Surf. B, 111, 755-763, 2013
32. Shete H., Patravale V. - Long chain lipid based tamoxifen NLC. Part I Preformulation studies, formulation development and physicochemical characterization - Int J. Pharm., 454, 573-583, 2013.
33. Freitas C, Muller R.H - Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. - Int. J. Pharm, 168, 221-229, 1998
34. Bunjes H., Unruh T - Characterization of lipid nanoparticles by differential scanning calonmetry, X-ray and neutron scattering - Adv. Drug Deliver. Rev., 59, 379-402, 2007.
35. Ali H, El-Sayed K., Sylvester PW., Nazzal S. - Molecular interaction and localization of tocotnenol-nch fraction (TRF) within the matrices of lipid nanoparticles evidence studies by differential scanning calorimetry (DSC) and proton nuclear magnetic resonance spectroscopy (H-1 NMR). - Colloids Surf B, 77, 286-297, 2010
36. Bunjes H., Koch M H J Westesen K. - Influence of emulsifiers on the crystallization of solid lipid nanoparticles - J. Pharm. Sci., 92, 1509-1520, 2003
37. Bunjes H, Koch M.H. J., Westesen K. - Effect of particle size on colloidal solid triglycerides - Langmuir, 16, 5234-5241, 2000.
38. Muller R H., Radtke M., Wissing S.A. - Nanostructured lipid matrices for improved microencapsulation of drugs - Int. J. Pharm., 242, 121-128, 2002.
39. Das S, Ng W.K., Tan R.B.H - Are nanostructured lipid carriers (NLCs) betterthan solid lipid nanoparticles (SLNs) development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? - Eur J. Pharm Sci, 47, 139-151, 2012.
40. Sato K - Crystallization behaviour of fats and lipids - a review - Chem. Eng. Sci, 56, 2255-2265, 2001.
41. Garcia-Gonzalez C A., da Sousa A.R.S., Argemi A., Periago A.L, Saunna J., Duarte CM.M., et al. - Production of hybrid lipid-based particles loaded with inorganic nanoparticles and active compounds for prolonged topical release. - Int. J. Pharm., 382, 296-304, 2009
42. Himawan C, Starov V.M, Stapley A.G - Thermodynamic and kinetic aspects offat crystallization. - Adv Colloid Interface Sci, 122, 3-33, 2006
43. O'Laughlin R., Sachs C, Brittam H., Cohen E. - Effects of variations in physicochemical properties of glyceryl monostearate on the stability of an oil-in. - J Soc. Cosmet Chem., 40, 215-229, 1989
44. Garcia-Gonzalez C.A., Sampaio da Sousa A R., Argemi A, Lopez Penago A., Saurma J., Duarte CM., et al. - Production of hybrid lipid-based particles loaded with inorganic nanoparticles and active compounds for prolonged topical release. - Int. J Pharm., 382, 296-304, 2009.
45. Yajima T, Itai S., Takeuchi H., Kawashima Y. - Determination of optimum processing temperature for transformation of glyceryl monostearate - Chem. Pharm Bull., 50, 1430-1433, 2002.
46. Cornish R.M. - Studies of glyceryl monostearate - J. Soc Cosmet Chem., 19, 109-117, 1968
47. Bunjes H., Westesen K., Koch M H J. - Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. - Int. J. Pharm., 129, 159-173, 1996.
48. Freitas C, Müller R. - Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase - Eur. J Pharm. Biopharm., 47, 125-132, 1999.
49. Shi G., Rao L, Yu H., Xiang H., Yang H., Ji R. - Stabilization and encapsulation of photosensitive resveratrol within yeast cell. - Int. J. Pharm., 349, 83-93, 2008.
50. Muller R.H., Mader K., Gohla S. - Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. - Eur J Pharm Biopharm, 50, 161-177, 2000.
51. Elnaggar Y., El-Massik M A, Abdallah O.Y. - Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. - Int J. Nanomed., 6, 3195-3205, 2010
52. zur Muhlen A., Schwarz C, Mehnert W. - Solid lipid nanoparticles (SLN) for controlled drug delivery, Drug release and release mechanism. - Eur. J Pharm. Biopharm., 45, 149-155, 1998
53. Bose S., Michniak-Kohn B. - Preparation and characterization of lipid based nanosystems for topical delivery of quercetin - Eur. J. Pharm Sci, 48, 442-452, 2013
54. Liu J., Hu W., Chen H, Ni Q., Xu H., Yang X. - Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. - Int. J. Pharm., 328, 191-195, 2007.
55. Muller R H., Petersen R.D., Hornmoss A., Pardeike J - Nanostructured lipid carriers (NLC) in cosmetic dermal products. - Adv. Drug Deliver. Rev, 59, 522-530, 2007
56. Schäfer-Korting M., Mehnert W., Korting H.-C. - Lipid nanoparticles for improved topical application of drugs for skin diseases. - Adv. Drug Deliver. Rev, 59, 427-443, 2007.
57. Puglia C, Blasi P., Rizza L., Schoubben A., Bonina F., Rossi C, et al. - Lipid nanoparticles for prolonged topical delivery An in vitro and in vivo investigation. - Int. J. Pharm., 357, 295-304, 2008.